Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global burden of hematologic malignancies and evolution patterns over the past 30 years
Nan Zhang, Jinxian Wu, Qian Wang, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 76
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 37
Unlocking the Therapeutic Potential of Algae-Derived Compounds in Hematological Malignancies
Tamara Vujović, Tina Paradžik, Sanja Babić, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 318-318
Open Access | Times Cited: 1
Checkpoint Inhibition Prior to Stem Cell Transplantation Increases the Risk of Inflammatory Adverse Events
Malek Shatila, Antonio Pizuorno Machado, Jay Shah, et al.
Targeted Oncology (2025)
Closed Access | Times Cited: 1
Polymeric nanoparticles as delivery vehicles for targeted delivery of chemotherapy drug fludarabine to treat hematological cancers
Mehrab Pourmadadi, Hamed Mirzaei Dehaghi, Amirhossein Ghaemi, et al.
Inorganic Chemistry Communications (2024) Vol. 167, pp. 112819-112819
Closed Access | Times Cited: 10
AML treatment: conventional chemotherapy and emerging novel agents
Mark Forsberg, Marina Konopleva
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 430-448
Closed Access | Times Cited: 8
Distributions and Trends of the Global Burden of Colorectal Cancer Attributable to Dietary Risk Factors over the Past 30 Years
Yuxing Liang, Nan Zhang, Miao Wang, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 132-132
Open Access | Times Cited: 19
Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 6
Teclistamab: Mechanism of action, clinical, and translational science
Yue Guo, Natalia A. Quijano Cardé, Lijuan Kang, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Global, Regional, and National Trends in Multiple Myeloma Burden from 1990 to 2021: An Analysis Based on Global Burden of Disease Study 2021
Song Zhou, Jing Zhou, Lianxiang Li, et al.
(2025)
Closed Access
Global Trends in the Incidence and Primary Causes of Femoral Fractures, Excluding Femoral Neck Fractures: A Global Epidemiological Study
Fanyu Fu, Bo Liu, Haifang Pu, et al.
Risk Management and Healthcare Policy (2025) Vol. Volume 18, pp. 117-129
Open Access
Outcomes of peripherally inserted central catheter vs conventional central venous catheters in hematological cancer patients: a systematic review and meta-analysis
Wei Ge, Zheng Chen
Hematology (2025) Vol. 30, Iss. 1
Open Access
Association of muscle strength and cardiorespiratory fitness with all-cause and cancer-specific mortality in patients diagnosed with cancer: a systematic review with meta-analysis
Francesco Bettariga, Daniel A. Galvão, Dennis R. Taaffe, et al.
British Journal of Sports Medicine (2025), pp. bjsports-108671
Closed Access
Therapeutic Vaccines for Hematological Cancers: A Scoping Review of This Immunotherapeutic Approach as Alternative to the Treatment of These Malignancies
Fernando Augusto Siqueira Mathias, Maria Gabriela Reis Carvalho, Jerônimo Conceição Ruiz
Vaccines (2025) Vol. 13, Iss. 2, pp. 114-114
Open Access
Cytokine-based immunotherapy in hematolymphoid malignancies
Mário Sousa‐Pimenta, Nuno R. dos Santos
International review of cell and molecular biology (2025)
Closed Access
A Bayesian Joint Model of Multiple Nonlinear Longitudinal and Competing Risks Outcomes for Dynamic Prediction in Multiple Myeloma: Joint Estimation and Corrected Two‐Stage Approaches
Danilo Alvares, Jessica Barrett, François Mercier, et al.
Statistics in Medicine (2025) Vol. 44, Iss. 3-4
Open Access
Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021
Linmin Zhuge, Xiaowu Lin, Ziwei Fan, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Natural Products in Leukemia Research: A Bibliometric Review
Siddig İbrahim Abdelwahab, Manal Mohamed Elhassan Taha, Syam Mohan
Journal of Herbal Medicine (2025) Vol. 50, pp. 100993-100993
Closed Access
Common cutaneous manifestations in hematological malignancies
Suchibrata Das
Journal of Hematology and Allied Sciences (2025), pp. 1-7
Closed Access
The changing burden of gout in adults aged 70 and above based on the global burden of disease 2019
Yang Yang, Zhong Liu
Frontiers in Public Health (2025) Vol. 13
Open Access
Unmet Needs and Health‐Related Quality of Life Among Patients With Relapsed/Refractory Indolent Non‐Hodgkin Lymphoma: A Mixed‐Methods Study
Miki Sugimoto, Kaori Yagasaki, Eri Matsuki, et al.
Psycho-Oncology (2025) Vol. 34, Iss. 2
Open Access
The Effect of Exercise-Based Interventions on Health-Related Quality of Life of Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis
Anita Borsati, Arianna Murri, Valentina Natalucci, et al.
Healthcare (2025) Vol. 13, Iss. 5, pp. 467-467
Open Access
Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis
Shanshan Tang, Jin Cao, Denan Jiang, et al.
Annals of Hematology (2025)
Open Access
mir-188‐5p emerges as an oncomir to promote chronic myeloid leukemia via upregulation of BUB3 and SUMO2
Osman Akıdan, Nina Petrović, Sema Mısır
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Lipids, apolipoproteins, carbohydrates, and risk of hematological malignancies
Qianwei Liu, Dang Wei, Niklas Hammar, et al.
European Journal of Epidemiology (2025)
Open Access
Page 1 - Next Page

Scroll to top